News Archive from February 2008
February 28, 2008
Researchers at Jefferson’s Kimmel Cancer Center in Philadelphia have shown that they can effectively kill prostate cancer cells in both the laboratory and in experimental animal models by blocking a signaling protein that is key to the cancer’s growth. The work proves that the protein, Stat5, is both vital to prostate cancer cell maintenance and that it is a viable target for drug therapy.
February 27, 2008
If clinical pharmacologist Scott Waldman, M.D., Ph.D., is right, a simple test for a marker involved in traveler’s diarrhea will help provide surgeons and oncologists with a more accurate picture of the extent of colorectal cancer in patients.
February 18, 2008
Mall shoppers and area residents will be able to take a walk through a colon while learning about colorectal cancer Thursday, February 28, when the Thomas Jefferson University Hospital Super Colon exhibit comes to Plymouth Meeting Mall.
February 14, 2008
Urologic researchers at Jefferson’s Kimmel Cancer Center in Philadelphia are studying whether high intensity focused ultrasound (HIFU) can be an effective treatment for low-risk prostate cancer and an alternative to using surgery, radiotherapy or cryosurgery.
February 13, 2008
Spine specialists at Thomas Jefferson University Hospital are expanding the field of minimally invasive spine surgery (MISS) by refining new techniques to correct even complex spinal deformities such as scoliosis and kyphosis.
February 12, 2008
Cataldo Doria, M.D, Ph.D., director of the Division of Transplantation at Thomas Jefferson University Hospital, and associate professor of Surgery at Jefferson Medical College, Thomas Jefferson University, has become a Fellow of the American College of Surgeons (ACS).
February 11, 2008
Liver cancer specialists at Jefferson’s Kimmel Cancer Center in Philadelphia are beginning an 18-month study of a new treatment for liver cancer. The therapy entails injecting tiny beads that emit small amounts of radiation into the liver’s main artery while also blocking the blood supply feeding the cancer’s growth.